94 research outputs found
Cultural adaptation of the Test of Narrative Language (TNL) into Brazilian Portuguese
Purpose: To accomplish the translation and cultural adaptation of the Test of Narrative Language (TNL) into Brazilian Portuguese.
Methods: The TNL is a formal instrument which assesses narrative comprehension and oral narration of children between the ages of 5-0 and 11-11 (years-months). The TNL translation and adaptation process had the following steps: (1) translation into the target language; (2) summary of the translated versions; (3) back-translation; (4) checking of the conceptual, semantics and cultural equivalence process and (5) pilot study (56 children within the test age range and from both genders).
Results: The adapted version maintained the same structure as the original version: number of tasks (both, three comprehension and oral narration), narrative formats (no picture, sequenced pictures and single picture) and scoring system. There were no adjustments to the pictures. The âMcDonaldâs Storyâ was replaced by the âSnack Bar Historyâ to meet the semantic and experiential equivalence of the target population. The other stories had semantic and grammatical adjustments. Statistically significant difference was found when comparing the raw score (comprehension, narration and total) of age groups from the adapted version.
Conclusion: Adjustments were required to meet the equivalence between the original and the translated versions. The adapted version showed it has the potential to identify differences in oral narratives of children in the age range provided by the test. Measurement equivalence for validation and test standardization are in progress and will be able to supplement the study outcomes
Evaluation of geometric tolerances using strain energy density
Traditionally, the geometric quality of assembled products has been evaluated by deviation from nominal values. However, the increased use mixed materials in especially automotive industry, in combination with an increased use of non-rigid simulation, open up for other evaluation criteria to complement the traditionally used deviation. The stiffness of a part or subassembly will, in combination with its deviation from nominal, give rise to different amounts of energy needed to join it to other parts. In this paper, the energy needed for joining is suggested as an evaluation criterion, complementary to geometric deviation, to judge the severity of the deviation
Recommended from our members
Monthlong Intubated Patient with Life-Threatening COVID-19 and Cerebral Microbleeds Suffers Only Mild Cognitive Sequelae at 8-Month Follow-up: A Case Report.
OBJECTIVE: To elaborate on possible cognitive sequelae related to COVID-19, associated cerebrovascular injuries as well as the general consequences from intensive care. COVID-19 is known to have several, serious CNS-related consequences, but neuropsychological studies of severe COVID-19 are still rare. METHODS: M., a 45-year-old man, who survived a severe COVID-19 disease course including Acute Respiratory Distress Syndrome (ARDS), cerebral microbleeds, and 35Â days of mechanical ventilation, is described. We elaborate on M's recovery and rehabilitation process from onset to the 8-month follow-up. The cognitive functions were evaluated with a comprehensive screening battery at 4 weeks after extubation and at the 8-month follow-up. RESULTS: Following extubation, M. was delirious, reported visual hallucinations, and had severe sleeping difficulties. At about 3Â months after COVID-19 onset, M. showed mild to moderate deficits on tests measuring processing speed, working memory, and attention. At assessments at 8 months, M. performed better, with results above average on tests measuring learning, memory, word fluency, and visuospatial functions. Minor deficits were still found regarding logical reasoning, attention, executive functioning, and processing speed. There were no lingering psychiatric symptoms. While M. had returned to a part-time job, he was not able to resume previous work-tasks. CONCLUSION: This case-study demonstrates possible cognitive deficits after severe COVID-19 and emphasizes the need of a neuropsychological follow-up, with tests sensitive to minor deficits. The main findings of this report provide some support that the long-term prognosis for cognition in severe COVID-19 may be hopeful
Testing of the functional mathematical model of analysis of mechanisms of linkage of universal energy tools and general purpose tractor
ĐŃДЎŃŃĐ°ĐČĐ»Đ”ĐœĐŸ ŃĐŸŃĐŒĐ°Đ»ĐžĐ·ĐŸĐČĐ°ĐœĐœĐŸĐ” ĐŸĐżĐžŃĐ°ĐœĐžĐ” ĐżŃĐŸĐČĐ”ŃĐșĐž ŃŃĐœĐșŃĐžĐŸĐœĐ°Đ»ŃĐœĐŸĐč ĐŒĐ°ŃĐ”ĐŒĐ°ŃĐžŃĐ”ŃĐșĐŸĐč ĐŒĐŸĐŽĐ”Đ»Đž ĐżŃĐŸŃĐ”ŃŃĐ° пДŃĐ”ĐČĐŸĐŽĐ° ĐČ ŃŃĐ°ĐœŃĐżĐŸŃŃĐœĐŸĐ” ĐżĐŸĐ»ĐŸĐ¶Đ”ĐœĐžĐ” ĐșĐŸŃОлĐșĐž-плŃŃОлĐșĐž ĐżŃĐžŃĐ”ĐżĐœĐŸĐč ĐĐĐ-4,2, Đ°ĐłŃДгаŃĐžŃŃĐ”ĐŒĐŸĐč Ń ŃĐœĐžĐČĐ”ŃŃĐ°Đ»ŃĐœŃĐŒ ŃĐœĐ”ŃгДŃĐžŃĐ”ŃĐșĐžĐŒ ŃŃДЎŃŃĐČĐŸĐŒ ĐŁĐĐĄ-2-280Đ Đž ŃŃĐ°ĐșŃĐŸŃĐŸĐŒ ĐŸĐ±ŃĐ”ĐłĐŸ ĐœĐ°Đ·ĐœĐ°ŃĐ”ĐœĐžŃ ĐĐĐĐĐ ĐŁĐĄ 2022. Đ Đ°ŃŃĐ”Ń ĐČŃŃ
ĐŸĐŽĐœŃŃ
паŃĐ°ĐŒĐ”ŃŃĐŸĐČ ĐŒĐ”Ń
Đ°ĐœĐžĐ·ĐŒĐŸĐČ ĐœĐ°ĐČĐ”ŃĐșĐž ĐŁĐĐĄ-2-280Đ Đž ĐĐĐĐĐ ĐŁĐĄ 2022 ĐČŃĐżĐŸĐ»ĐœĐ”Đœ Ń ĐżĐŸĐŒĐŸŃŃŃ ŃазлОŃĐœŃŃ
Đ°ĐœĐ°Đ»ĐžŃĐžŃĐ”ŃĐșĐžŃ
ĐČŃŃĐ°Đ¶Đ”ĐœĐžĐč. ĐĐŽĐ”ĐœŃĐžŃĐœĐŸŃŃŃ ŃŃĐ°ĐČĐœĐžĐČĐ°Đ”ĐŒŃŃ
ŃДзŃĐ»ŃŃĐ°ŃĐŸĐČ ŃĐ°ŃŃĐ”ŃĐ° ĐČŃŃ
ĐŸĐŽĐœŃŃ
паŃĐ°ĐŒĐ”ŃŃĐŸĐČ ĐŒĐ”Ń
Đ°ĐœĐžĐ·ĐŒĐŸĐČ ĐœĐ°ĐČĐ”ŃĐșĐž ĐŁĐĐĄ-2-280Đ Đž ĐĐĐĐĐ ĐŁĐĄ 2022 ĐżĐŸĐ·ĐČĐŸĐ»ŃĐ”Ń ŃЎДлаŃŃ ĐČŃĐČĐŸĐŽ ĐŸ ĐżŃĐ°ĐČОлŃĐœĐŸŃŃĐž ŃĐ°Đ·ŃĐ°Đ±ĐŸŃĐ°ĐœĐœĐŸĐč ŃŃĐœĐșŃĐžĐŸĐœĐ°Đ»ŃĐœĐŸĐč ĐŒĐ°ŃĐ”ĐŒĐ°ŃĐžŃĐ”ŃĐșĐŸĐč ĐŒĐŸĐŽĐ”Đ»Đž ĐŒĐ”Ń
Đ°ĐœĐžĐ·ĐŒĐ° ĐœĐ°ĐČĐ”ŃĐșĐž, ŃŃŃĐ”ĐșŃĐžĐČĐœĐŸĐč ĐŽĐ»Ń ĐŒĐŸĐ±ĐžĐ»ŃĐœŃŃ
ŃĐœĐ”ŃгДŃĐžŃĐ”ŃĐșĐžŃ
ŃŃДЎŃŃĐČ.The article presents a formalized description of the checking of the functional mathematical model of the process of transferring to transport position of pull-type mower conditioners PTMC-4,2, aggregated with universal power tool UPT-2-280Đ and general-purpose tractor BELARUS 2022. Calculation of the output parameters of linkage mechanisms UPT-2-280Đ and BELARUS 2022 is performed using various analytical expressions. The identity of the compared results of calculating the output parameters of the linkage mechanisms UPT-2-280Đ and BELARUS 2022 allows to make a conclusion about the correctness of the developed functional mathematical model of the linkage mechanism, effective for mobile power equipment
Pleosporales
One hundred and five generic types of Pleosporales are described and illustrated. A brief introduction and detailed history with short notes on morphology, molecular phylogeny as well as a general conclusion of each genus are provided. For those genera where the type or a representative specimen is unavailable, a brief note is given. Altogether 174 genera of Pleosporales are treated. Phaeotrichaceae as well as Kriegeriella, Zeuctomorpha and Muroia are excluded from Pleosporales. Based on the multigene phylogenetic analysis, the suborder Massarineae is emended to accommodate five families, viz. Lentitheciaceae, Massarinaceae, Montagnulaceae, Morosphaeriaceae and Trematosphaeriaceae
Ageism and sexuality
Sexuality remains important throughout a personâs life, but sexual behavior does not receive the same levels of acceptance at all ages. Older people are challenged by ageist attitudes and perceptions that hinder their sexual expression. They are stereotyped as non-sexual beings who should not, cannot, and do not want to have sexual relationships. Expressing sexuality or engaging in sexual activity in later life is considered by many in society as immoral or perverted. False expectations for older people also stem from ideals of beauty, centralization of the biomedical perspective on sexuality of older adults, and the association of sex with reproduction. Unfortunately, older people internalize many ageist attitudes towards sexuality in later life and become less interested in sex and less sexually active. The following chapter explores attitudes towards sexuality in later life among the media, young people, older people themselves, and care providers. In order to enable older people to express their sexuality and sexual identity freely and fully, awareness of ageist perceptions must be raised and defeated
Potential of FX06 to prevent disease progression in hospitalized non-intubated COVID-19 patients â the randomized, EU-wide, placebo-controlled, phase II study design of IXION
Background: More than 2.7 million hospitalizations of COVID-19-infected patients have occurred in Europe alone since the outbreak of the coronavirus in 2020. Interventions against SARS-CoV-2 are still in high need to prevent admissions to ICUs worldwide. FX06, a naturally occurring peptide in humans and other mammals, has the potential to reduce capillary leak by improving endothelial dysfunction and thus preventing the deterioration of patients. With IXION, we want to investigate the potential of FX06 to prevent disease progression in hospitalized, non-intubated COVID-19 patients. Methods: IXION is an EU-wide, multicentre, placebo-controlled, double-blinded, parallel, randomized (2:1) phase II clinical study. Patient recruitment will start in September 2022 (to Q2/2023) in Germany, Italy, Lithuania, Spain, Romania, Portugal, and France. A total of 306 hospitalized patients (>= 18 years and < 75 years) with a positive SARS-CoV-2 PCR test and a COVID-19 severity of 4-6 according to the WHO scale will be enrolled. After randomization to FX06 or placebo, patients will be assessed until day 28 (and followed up until day 60). FX06 (2 x 200 mg per day) or placebo will be administered intravenously for 5 consecutive days. The primary endpoint is to demonstrate a difference in the proportion of patients with progressed/worsened disease state in patients receiving FX06 compared to patients receiving placebo. Secondary endpoints are lung function, oxygen saturation and breathing rate, systemic inflammation, survival, capillary refill time, duration of hospital stay, and drug accountability. Discussion: With IXION, the multidisciplinary consortium aims to deliver a new therapy in addition to standard care against SARS-CoV-2 for the clinical management of COVID-19 during mild and moderate stages. Potential limitations might refer to a lack of recruiting and drop-out due to various possible protocol violations. While we controlled for drop-outs in the same size estimation, recruitment problems may be subject to external problems difficult to control for
Increased Risk of Fragility Fractures among HIV Infected Compared to Uninfected Male Veterans
BACKGROUND: HIV infection has been associated with an increased risk of fragility fracture. We explored whether or not this increased risk persisted in HIV infected and uninfected men when controlling for traditional fragility fracture risk factors. METHODOLOGY/PRINCIPAL FINDINGS: Cox regression models were used to assess the association of HIV infection with the risk for incident hip, vertebral, or upper arm fracture in male Veterans enrolled in the Veterans Aging Cohort Study Virtual Cohort (VACS-VC). We calculated adjusted hazard ratios comparing HIV status and controlling for demographics and other established risk factors. The sample consisted of 119,318 men, 33% of whom were HIV infected (34% aged 50 years or older at baseline, and 55% black or Hispanic). Median body mass index (BMI) was lower in HIV infected compared with uninfected men (25 vs. 28 kg/mÂČ; p<0.0001). Unadjusted risk for fracture was higher among HIV infected compared with uninfected men [HR: 1.32 (95% CI: 1.20, 1.47)]. After adjusting for demographics, comorbid disease, smoking and alcohol abuse, HIV infection remained associated with an increased fracture risk [HR: 1.24 (95% CI: 1.11, 1.39)]. However, adjusting for BMI attenuated this association [HR: 1.10 (95% CI: 0.97, 1.25)]. The only HIV-specific factor associated with fragility fracture was current protease inhibitor use [HR: 1.41 (95% CI: 1.16, 1.70)]. CONCLUSIONS/SIGNIFICANCE: HIV infection is associated with fragility fracture risk. This risk is attenuated by BMI
Peri-operative red blood cell transfusion in neonates and infants: NEonate and Children audiT of Anaesthesia pRactice IN Europe: A prospective European multicentre observational study
BACKGROUND: Little is known about current clinical practice concerning peri-operative red blood cell transfusion in neonates and small infants. Guidelines suggest transfusions based on haemoglobin thresholds ranging from 8.5 to 12âgâdl-1, distinguishing between children from birth to day 7 (week 1), from day 8 to day 14 (week 2) or from day 15 (â„week 3) onwards. OBJECTIVE: To observe peri-operative red blood cell transfusion practice according to guidelines in relation to patient outcome. DESIGN: A multicentre observational study. SETTING: The NEonate-Children sTudy of Anaesthesia pRactice IN Europe (NECTARINE) trial recruited patients up to 60 weeks' postmenstrual age undergoing anaesthesia for surgical or diagnostic procedures from 165 centres in 31 European countries between March 2016 and January 2017. PATIENTS: The data included 5609 patients undergoing 6542 procedures. Inclusion criteria was a peri-operative red blood cell transfusion. MAIN OUTCOME MEASURES: The primary endpoint was the haemoglobin level triggering a transfusion for neonates in week 1, week 2 and week 3. Secondary endpoints were transfusion volumes, 'delta haemoglobin' (preprocedure - transfusion-triggering) and 30-day and 90-day morbidity and mortality. RESULTS: Peri-operative red blood cell transfusions were recorded during 447 procedures (6.9%). The median haemoglobin levels triggering a transfusion were 9.6 [IQR 8.7 to 10.9] gâdl-1 for neonates in week 1, 9.6 [7.7 to 10.4] gâdl-1 in week 2 and 8.0 [7.3 to 9.0] gâdl-1 in week 3. The median transfusion volume was 17.1 [11.1 to 26.4] mlâkg-1 with a median delta haemoglobin of 1.8 [0.0 to 3.6] gâdl-1. Thirty-day morbidity was 47.8% with an overall mortality of 11.3%. CONCLUSIONS: Results indicate lower transfusion-triggering haemoglobin thresholds in clinical practice than suggested by current guidelines. The high morbidity and mortality of this NECTARINE sub-cohort calls for investigative action and evidence-based guidelines addressing peri-operative red blood cell transfusions strategies. TRIAL REGISTRATION: ClinicalTrials.gov, identifier: NCT02350348
- âŠ